Entrada Therapeutics, Inc.

TRDA

—

Advanced chart & tools →

Entrada Therapeutics, Inc.TRDA

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-3.47

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$25.42M

Net income

$-143.75M

Net margin

-565.5%

Gross margin

—

Dividends & financials

Entrada Therapeutics, Inc. (TRDA) reported revenue of $25.42M and net income of $-143.75M, or $-3.47 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.